Berenberg Bank set a €110.00 ($129.41) price objective on Merck KGaA (FRA:MRK) in a research note issued to investors on Thursday. The firm currently has a neutral rating on the healthcare company’s stock.
A number of other equities research analysts have also issued reports on MRK. J P Morgan Chase & Co set a €100.00 ($117.65) price target on Merck KGaA and gave the company a neutral rating in a research report on Wednesday, July 26th. Kepler Capital Markets set a €119.00 ($140.00) price target on Merck KGaA and gave the company a buy rating in a research report on Monday, July 31st. Deutsche Bank AG set a €106.00 ($124.71) price target on Merck KGaA and gave the company a neutral rating in a research report on Wednesday, July 26th. Goldman Sachs Group, Inc. (The) set a €110.00 ($129.41) price target on Merck KGaA and gave the company a neutral rating in a research report on Thursday, July 27th. Finally, Morgan Stanley set a €103.00 ($121.18) price target on Merck KGaA and gave the company a neutral rating in a research report on Monday, May 22nd. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and six have assigned a buy rating to the company. Merck KGaA presently has an average rating of Hold and a consensus price target of €108.81 ($128.01).
Merck KGaA (FRA MRK) opened at 92.268 on Thursday. The firm has a 50-day moving average of €103.27 and a 200-day moving average of €104.45. The company has a market capitalization of €40.06 billion and a P/E ratio of 25.723. Merck KGaA has a one year low of €89.00 and a one year high of €115.00.
About Merck KGaA
.
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
